Inify Laboratories AB

Share Issue/Capital Change • Jan 12, 2026

Inify Laboratories - Commencement of subscription period for Repair Issue

Inify Laboratories - Commencement of subscription period for Repair Issue

STOCKHOLM - 12 January 2026 - Reference is made to the stock exchange

announcement made by Inify Laboratories AB (the "Company") on 19 December 2025

regarding the final results of the fully guaranteed private placement (the

"Private Placement"). Further, reference is made to the stock exchange

announcement made by the Company on 17 December 2025 and previous announcements

regarding the fully guaranteed repair issue of 2,304,563 new shares (the "Repair

Issue"). The Repair Issue will be directed pro-rata towards existing

shareholders that did not participate in the Private Placement and who hold less

than 1,000,000 shares in the Company. The offer price per share in the Repair

Issue is NOK 3.50 (the "Offer Price"), equal to the subscription price in the

Private Placement.

The subscription period for the Repair Issue (the "Subscription Period")

commences today, 12 January 2026 at 09:00 (CET) and expires on 26 January 2026

at 16:30 (CET), unless extended at the Company's sole discretion.

The Repair Issue is, subject to applicable securities law, directed pro-rata

towards existing shareholders in the Company as of 16 December 2025 (as

registered in Euronext Securities Oslo (the "VPS") or the share register

maintained by Euroclear Sweden Ab ("Euroclear"), as applicable, on 18 December

2025 (the "Record Date")), who (i) were not eligible to participate in the

Private Placement, and (ii) are not resident in a jurisdiction where such

offering would be unlawful or, would require any prospectus, filing,

registration or similar action ("Eligible Shareholders").

Eligible Shareholders with shares registered with the VPS as of the Record Date

will receive 0.3621 non-tradable subscription rights for each share held by such

Eligible Shareholder in the Company as of the Record Date, subject to certain

limitations based on applicable laws and regulations, that will give right to

subscribe for, and be allocated, one (1) share in the Repair Issue (the "Repair

Issue Shares") at the Offer Price. The number of subscription rights granted to

each Eligible Shareholder will be rounded down to the nearest whole subscription

right. Over-subscription is not allowed. Shareholders with shares registered

directly with Euroclear as of the Record Date will not receive any subscription

rights. Instead, such shareholders will receive an application form which shall

be used to apply for subscription for shares in the Repair Issue.

The following allocation criteria will be used for allotment of Repair Issue

Shares in the Repair Issue:

(i)                  Allocation of the Repair Issue Shares will be made to

subscribers on the basis of granted subscription rights which have been validly

exercised during the Subscription Period. Each subscription right will give the

right to subscribe for and be allocated one (1) Repair Issue Share.

(ii)                If not all subscription rights are validly exercised in the

Subscription Period, allotment shall be made to Monsun AS and Auris AS (the

"Guarantors"), companies controlled by the same owners as the Company's two

largest shareholders Gallivant S.à r.l. and Tauri AS, respectively, in

proportion to the size of their respective share of the guarantee commitment,

and to the extent that this cannot be done, by drawing lots.

Only Eligible Shareholders may participate in the Repair Issue. Subscription

without subscription rights is not permitted (save for subscriptions by the

Guarantors in accordance with the allocation principles set out above).

Allocation of fewer Repair Issue Shares than subscribed for by a subscriber will

not impact the subscriber's obligation to pay for the number of Repair Issue

Shares allocated. The Company will not allocate fractional Repair Issue Shares.

The Company reserves the right to round off, reject or reduce any subscription

for Repair Issue Shares.

Notifications of allocation of Repair Issue Shares and the corresponding

subscription amount to be paid by each subscriber are expected to be distributed

by SB1 Markets AS (the "Manager") on or around 28 January 2026. Subscribers who

have access to investor services through their VPS account manager is expected

to be able to check the number of Repair Issue Shares allocated to them from

around 15:00 CET on 28 January 2026. Subscribers who do not have access to

investor services through their VPS account manager is expected to be able to

contact the Manager from 15:00 CET on 28 January 2026 to obtain information

about the number of Repair Issue Shares allocated to them.

The subscription rights must be used to subscribe for shares in the Repair Issue

prior to expiry of the Subscription Period. Subscription rights that are not

used to subscribe for shares in the Repair Issue before the expiry of the

Subscription Period will have no value and will lapse without compensation to

the holder.

The date for payment of the Repair Issue is expected to be on or about 25 March

2026 (the "Payment Date"). The new shares in the Repair Issue are expected to be

delivered on or about 30 March 2026, subject to turnaround time for registration

of the share capital increases relating to the Repair Issue with the Swedish

Companies Registration Office ("SCRO"). The shares allocated in the Repair Issue

will be tradable on Euronext Growth Oslo when the new shares have been

registered with the SCRO and registered by Euroclear Sweden and VPS,

respectively, expected on or about 30 March 2026.

Subscription for new shares in the Repair Issue is made by submitting a

correctly completed subscription form to SB1 Markets AS, the manager in the

Repair Issue (the "Manager"), per e-mail or ordinary post as described in the

subscription form. The subscription form will be available at

http://www.sb1markets.no/transaksjoner/ and will also be sent by post to all

Eligible Shareholders.  Subscribers who are resident in Norway and have a

Norwegian national identification number are encouraged to subscribe for new

shares in the Repair Issue through the VPS online subscription system (or by

following the link on http://www.sb1markets.no/transaksjoner/, which will

redirect the subscriber to the VPS online subscription system).

Company update - webinar on 23 January 2026 at 12:30 (CET)

The Company will host a webinar where the Company's CEO, Fredrik Palm, will

provide a company update and also answer any questions regarding the Repair

Issue and the Private Placement. The webinar will be held on 23 January 2026 at

12:30 (CET). For registration, please send an e-mail to

corporateaccess@sb1markets.no.

Advisors

SB1 Markets AS ("SB1 Markets") has been appointed as financial advisor in

connection with the Private Placement and the Repair Issue. Schjødt law firm

acts as legal counsel to the Company.

For further information, please contact CEO, Fredrik Palm,

fredrik.palm@inify.com, or visit https://www.inify.com

The future of diagnostics

Inify Laboratories offers diagnostics through specialised laboratory services in

histopathology, with a focus on streamlining patient pathways. The company

performs clinical diagnostics in prostate cancer and gastroenterology, providing

an integrated service that spans from early sample handling to final diagnosis.

The laboratory system is scalable both in handling large volumes of patient

samples and for replicating in new locations.

Quality and response times are optimised in every step - from logistics to

tissue preparation and diagnosis - using a fully digital, standardised and AI

-assisted workflow. The diagnosis is always performed by a pathologist and is

assisted by Inify's proprietary AI, proven to have world-leading precision in

clinical evaluations. The entire workflow is supported by a tailor-made system

that also enables development to include additional diagnostic areas.

Inify Laboratories is an international group headquartered in Stockholm, Sweden,

with local laboratories in Sweden and the UK. The company's share is listed on

Euronext Growth Oslo (https://live.euronext.com/en/product/equities/SE0017486103

-MERK) under the ticker

INIFY. (https://live.euronext.com/en/product/equities/SE0017486103-MERK)

This information is subject to the disclosure requirements pursuant to section 5

-12 the Norwegian Securities Trading Act.

Important information

The release, announcement or distribution of this press release may, in certain

jurisdictions, be subject to restrictions. The recipients of this press release

in jurisdictions where this press release has been published or distributed

shall inform themselves of and follow such restrictions. The recipient of this

press release is responsible for using this press release, and the information

contained herein, in accordance with applicable rules in each jurisdiction. The

information in this press release does not contain or constitute an offer to

acquire, subscribe or otherwise trade in shares, subscription rights or other

securities in the Company in any jurisdiction.

This press release does not identify or suggest, or purport to identify or

suggest, the risks (direct or indirect) that may be associated with an

investment in new shares. Any investment decision in connection with the Private

Placement and the Repair Issue must be made on the basis of all publicly

available information relating to the Company and the Company's shares. Such

information has not been independently verified by SB1 Markets. The information

contained in this announcement is for background purposes only and does not

purport to be full or complete. No reliance may be placed for any purpose on the

information contained in this announcement or its accuracy or completeness. SB1

Markets is acting for the Company in connection with the transaction and no one

else and will not be responsible to anyone other than the Company for providing

the protections afforded to its clients nor for giving advice in relation to the

transaction or any other matter referred to herein.

This press release does not constitute a recommendation concerning any

investor's option with respect to the Private Placement and the Repair Issue.

Each investor or prospective investor should conduct his, her or its own

investigation, analysis and evaluation of the business and data described in

this announcement and publicly available information. The price and value of

securities can go down as well as up. Past performance is not a guide to future

performance.

The information contained in this press release is not intended for, and must

not be accessed by, or distributed or disseminated, directly or indirectly, in

whole or in part, to persons resident or physically present in the United States

of America (including its territories and possessions, any state of the United

States and the District of Columbia) (the "United States"), Australia, Canada,

Hong Kong, Japan, New Zealand, Singapore, South Africa, United Kingdom or any

other jurisdiction where such action is wholly or partially subject to legal

restrictions, or would require additional prospectuses, registration or other

measures than those required by Norwegian law. The information in the press

release does not constitute any offer regarding subscription rights, paid

subscribed shares or shares in the Company ("Securities") to any person in said

jurisdictions. The information in the press release may not be forwarded or

reproduced in such a manner that contravenes such restrictions or gives cause to

such requirements.

No securities have been or will be registered under the United States Securities

Act of 1933, as amended (the "Securities Act") or the securities legislation of

any state or other jurisdiction in the United States and may not be offered,

subscribed for, exercised, used, pledged, sold, resold, granted, delivered or

otherwise transferred, directly or indirectly, in or into the United States

except pursuant to an applicable exemption from, or in a transaction not subject

to, the registration requirements under the Securities Act and in compliance

with the securities legislation in the relevant state or any other jurisdiction

of the United States.

Within the European Economic Area ("EEA"), no public offering of Securities is

made in other countries than Sweden or Norway. In other member states of the EU,

such an offering of Securities may only be made in accordance with the

Prospectus Regulation (EU) 2017/1129 (the "Prospectus Regulation"). In other

member states of the EEA which have implemented the Prospectus Regulation in its

national legislation, any offer of Securities may only be made in accordance

with an applicable exemption in the Prospectus Regulation and/or in accordance

with an applicable exemption under a relevant national implementation measure.

In the United Kingdom, this document and any other materials in relation to the

securities described herein is only being distributed to, and is only directed

at, and any investment or investment activity to which this document relates is

available only to, and will be engaged in only with, "qualified investors" who

are (i) persons having professional experience in matters relating to

investments who fall within the definition of "investment professionals" in

Article 19(5) of the Financial Services and Markets Act 2000 (Financial

Promotion) Order 2005 (the "Order"); or (ii) high net worth entities falling

within Article 49(2)(a) to (d) of the Order (all such persons together being

referred to as "relevant persons"). In the United Kingdom, any investment or

investment activity to which this communication relates is available only to,

and will be engaged in only with, relevant persons. Persons who are not relevant

persons should not take any action on the basis of this press release and should

not act or rely on it.

Forward-looking statements

This press release contains forward-looking statements that reflect the

Company's intentions, beliefs, or current expectations about and targets for the

Company's future results of operations, financial condition, liquidity,

performance, prospects, anticipated growth, strategies and opportunities and the

markets in which the Company's operates. Forward-looking statements are

statements that are not historical facts and may be identified by words such as

"believe", "expect", "anticipate", "intend", "may", "plan", "estimate", "will",

"should", "could", "aim" or "might", or, in each case, their negative, or

similar expressions. The forward-looking statements in this press release are

based upon various assumptions, many of which are based, in turn, upon further

assumptions. Although the Company believes that the expectations reflected in

these forward-looking statements are reasonable, it can give no assurances that

they will materialize or prove to be correct. Because these statements are based

on assumptions or estimates and are subject to risks and uncertainties, the

actual results or outcome could differ materially from those set out in the

forward-looking statements as a result of many factors. Such risks,

uncertainties, contingencies and other important factors could cause actual

events to differ materially from the expectations expressed or implied in this

release by such forward-looking statements. The Company does not guarantee that

the assumptions underlying the forward-looking statements in this press release

are free from errors and readers of this press release should not place undue

reliance on the forward-looking statements in this press release. The

information, opinions and forward-looking statements that are expressly or

implicitly contained herein speak only as of its date and are subject to change

without notice. Neither the Company nor anyone else undertake to review, update,

confirm or to release publicly any revisions to any forward-looking statements

to reflect events that occur or circumstances that arise in relation to the

content of this press release.

FDI

The Company assesses that it conducts a business of strategic interest under the

Act (2023:560) on the Review of Foreign Direct Investments (the "FDI Act"). In

accordance with the FDI Act, the Company must inform potential investors that

its operations may fall within the scope of the regulation and that the

investment may be subject to a notification requirement. If an investment is

subject to notification, it must be reported to the Inspectorate of Strategic

Products (ISP) before being completed. An investment may be subject to

notification if the investor, any entity within its ownership structure, or any

party on whose behalf the investor is acting, following the completion of the

investment, holds voting rights corresponding to or exceeding any of the

thresholds of 10, 20, 30, 50, 65, or 90 percent of the total number of votes in

the Company. The investor may be subject to an administrative sanction fee if a

notifiable investment is carried out before ISP has either: i) decided to take

no action on the notification, or ii) approved the investment. Each shareholder

should consult an independent legal advisor regarding the potential

applicability of the FDI Act in relation to the Private Placement and the Repair

Issue for the individual shareholder.

Information to distributors

Solely for the purposes of the product governance requirements contained within:

(a) EU Directive 2014/65/EU on markets in financial instruments, as amended

("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU)

2017/593 supplementing MiFID II; and (c) local implementing measures (together,

the "MiFID II Product Governance Requirements"), and disclaiming all and any

liability, whether arising in tort, contract or otherwise, which any

"manufacturer" (for the purposes of the MiFID II Product Governance

Requirements) may otherwise have with respect thereto, the shares in the Company

have been subject to a product approval process, which has determined that such

shares are: (i) compatible with an end target market of retail investors and

investors who meet the criteria of professional clients and eligible

counterparties, each as defined in MiFID II; and (ii) eligible for distribution

through all distribution channels as are permitted by MiFID II (the "Target

Market Assessment"). Notwithstanding the Target Market Assessment, Distributors

should note that: the price of the shares in the Company may decline and

investors could lose all or part of their investment; the shares in The Company

offer no guaranteed income and no capital protection; and an investment in the

shares in the Company is compatible only with investors who do not need a

guaranteed income or capital protection, who (either alone or in conjunction

with an appropriate financial or other adviser) are capable of evaluating the

merits and risks of such an investment and who have sufficient resources to be

able to bear any losses that may result therefrom. The Target Market Assessment

is without prejudice to the requirements of any contractual, legal or regulatory

selling restrictions in relation to the new share issue. Furthermore, it is

noted that, notwithstanding the Target Market Assessment, SB1 Markets will only

procure investors who meet the criteria of professional clients and eligible

counterparties.

For the avoidance of doubt, the Target Market Assessment does not constitute:

(a) an assessment of suitability or appropriateness for the purposes of MiFID

II; or (b) a recommendation to any investor or group of investors to invest in,

or purchase, or take any other action whatsoever with respect to the shares in

the Company.

Each distributor is responsible for undertaking its own target market assessment

in respect of the shares in the Company and determining appropriate distribution

channels.